tirzepatide shot locations Understanding Injection Sites for Tirzepatide: A Comprehensive Guide Tutorial on how to inject

GLP-1 receptor agonists have revolutionized weight management, but discontinuing them requires careful planning to maintain results and avoid rebound weight gain

2.2 Indications The currently approved indications for these agents include: Type 2 diabetes mellitus Overweight and obesity Beyond diabetes and obesity, further indications under investigation for GLP1 RAs include: Osteoarthritis Obstructive sleep apnea Metabolic dysfunction-associated steatotic liver disease Metabolic dysfunction-associated steatohepatitis 2.3 Benefits and Harms of Continuation/Discontinuation in the Perioperative Period: 2.3.1 Benefits: According to the guidelines, the acute use of these drugs may offer benefits based on published data: Improved perioperative glycemic control Lower postoperative insulin requirements Reduced risk of hypoglycemia These benefits may lead to reduced complications associated with hyperglycemia (such as a shorter hospital stay, fewer surgical site infections, less acute kidney injury, fewer acute coronary syndromes, reduced critical care admissions, and shorter durations on a ventilator) Improved cardiovascular outcomes 2.3.2 Harms There is an increased risk of pulmonary aspiration

Pleasure serves an adaptive role, and that adaptive role relates to the fact that every species has a primary goal, which is to make more of itself, otherwise it would go extinct

The journey of weight management with Tirzepatide is ongoing and requires consistent behavior change

(BS) - GLP-1